delavirdine has been researched along with thiourea in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ekstrand, DH; Gronowitz, JS; Källander, CF; Rytting, AS; Shao, X; Vrang, L | 1 |
Mao, C; Sudbeck, EA; Uckun, FM; Venkatachalam, TK | 1 |
Ariën, KK; Heyndrickx, L; Michiels, J; Quiñones-Mateu, ME; Selhorst, P; Terrazas-Aranda, K; Vanham, G; Vazquez, AC; Vereecken, K; Weber, J | 1 |
3 other study(ies) available for delavirdine and thiourea
Article | Year |
---|---|
Colorimetric assays for evaluation of the mode of action of human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors.
Topics: Amino Acid Sequence; Anti-HIV Agents; Benzodiazepines; Colorimetry; Delavirdine; Drug Evaluation; Enzyme-Linked Immunosorbent Assay; HIV Reverse Transcriptase; HIV-1; Imidazoles; Molecular Sequence Data; Nevirapine; Pyridines; Recombinant Proteins; Reverse Transcriptase Inhibitors; Templates, Genetic; Thiourea | 1998 |
Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus.
Topics: Anti-HIV Agents; Delavirdine; Drug Design; Humans; Inhibitory Concentration 50; Kinetics; Models, Molecular; Nevirapine; Pyridines; Thiourea | 1999 |
Human immunodeficiency virus type 1 resistance or cross-resistance to nonnucleoside reverse transcriptase inhibitors currently under development as microbicides.
Topics: Alkynes; Anilides; Anti-Infective Agents; Benzoxazines; Cell Line; Cells, Cultured; Cyclopropanes; Delavirdine; Drug Resistance, Viral; Furans; Genotype; HIV-1; Humans; Nevirapine; Reverse Transcriptase Inhibitors; Thiazoles; Thioamides; Thiourea | 2011 |